Kim L Gratz1, Donna M Lacroce, John G Gunderson. 1. McLean Hospital and Harvard Medical School, and University of Maryland, College Park, MD 20742, USA. KLGratz@aol.com
Abstract
OBJECTIVE: This study examined whether measurable changes in symptoms relevant to borderline personality disorder (BPD) occur following short-term treatment across partial hospital and intensive outpatient levels of care. Preliminary data on symptom changes among patients with BPD during the first 3 months of treatment in a step-down treatment program are presented. METHODS: Of the 42 patients who entered the BPD-specific treatment program during the 18-month study period, 36 consented to participate in the study. Patients began treatment in the partial hospitalization program (where the average length of stay is 8 weeks) and then transitioned into the intensive outpatient program. Patients completed questionnaire packets upon admission, and again at 1 month and 3 months into treatment. The questionnaires assessed BPD-relevant behaviors and symptoms, including: mood and emotion dysregulation, parasuicidality, symptom severity, and quality of life. RESULTS: Results indicate significant and progressive improvements in mood and emotion dysregulation, parasuicidality, and symptom severity following 1 and 3 months of treatment. However, neither global functioning nor quality of life dramatically improved. CONCLUSIONS: The findings from this study highlight the amenability of BPD-relevant symptoms to short-term treatments and demonstrate the possibility of measuring change in these symptoms within the very early phases of treatment.
OBJECTIVE: This study examined whether measurable changes in symptoms relevant to borderline personality disorder (BPD) occur following short-term treatment across partial hospital and intensive outpatient levels of care. Preliminary data on symptom changes among patients with BPD during the first 3 months of treatment in a step-down treatment program are presented. METHODS: Of the 42 patients who entered the BPD-specific treatment program during the 18-month study period, 36 consented to participate in the study. Patients began treatment in the partial hospitalization program (where the average length of stay is 8 weeks) and then transitioned into the intensive outpatient program. Patients completed questionnaire packets upon admission, and again at 1 month and 3 months into treatment. The questionnaires assessed BPD-relevant behaviors and symptoms, including: mood and emotion dysregulation, parasuicidality, symptom severity, and quality of life. RESULTS: Results indicate significant and progressive improvements in mood and emotion dysregulation, parasuicidality, and symptom severity following 1 and 3 months of treatment. However, neither global functioning nor quality of life dramatically improved. CONCLUSIONS: The findings from this study highlight the amenability of BPD-relevant symptoms to short-term treatments and demonstrate the possibility of measuring change in these symptoms within the very early phases of treatment.
Authors: Susan V Eisen; Pradipta Seal; Mark E Glickman; Dharma E Cortés; Mariana Gerena-Melia; Sergio Aguilar-Gaxiola; Vivian E Febo San Miguel; Jesús Soto-Espinosa; Cristina Magaña; Glorisa Canino Journal: J Behav Health Serv Res Date: 2009-03-28 Impact factor: 1.505
Authors: Jessica R Peters; Ethan H Mereish; Maya A Krek; Adam Chuong; Megan L Ranney; Joel Solomon; Anthony Spirito; Shirley Yen Journal: Psychiatry Res Date: 2019-10-28 Impact factor: 3.222
Authors: J Christopher Fowler; Jon G Allen; John M Hart; Hanna Szlykh; Thomas E Ellis; B Christopher Frueh; John M Oldham Journal: Borderline Personal Disord Emot Dysregul Date: 2014-12-15